Cited by 411interferon and immune responsesImmune Response and InflammationImmunotherapy and Immune Responses

The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.

The Interferon Regulatory Factor, IRF5, Is a Central Mediator of Toll-like Receptor 7 Signaling

Open access

Schoenemeyer, Annett, Barnes, Betsy J., Mancl, Margo.E., Latz, Eicke, Goutagny, Nadege, Pitha, Paula M., Fitzgerald, Katherine A., Golenbock, Douglas T.·2005·Journal of Biological Chemistry

DOI 10.1074/jbc.m412584200

Open this paper in CoChat — free account

Abstract

Interferon regulatory factors (IRFs) are critical components of virus-induced immune activation and type I interferon regulation. IRF3 and IRF7 are activated in response to a variety of viruses or after engagement of Toll-like receptor (TLR) 3 and TLR4 by double-stranded RNA and lipopolysaccharide, respectively. The activation of IRF5, is much more restricted. Here we show that in contrast to IRF3 and IRF7, IRF5 is not a target of the TLR3 signaling pathway but is activated by TLR7 or TLR8 signaling. We also demonstrate that MyD88, interleukin 1 receptor-associated kinase 1, and tumor necrosis factor receptor-associated factor 6 are required for the activation of IRF5 and IRF7 in the TLR7 signaling pathway. Moreover, ectopic expression of IRF5 enabled type I interferon production in response to TLR7 signaling, whereas knockdown of IRF5 by small interfering RNA reduced type I interferon induction in response to the TLR7 ligand, R-848. IRF5 and IRF7, therefore, emerge from these studies as critical mediators of TLR7 signaling.

Integrity signals

Registry

Crossref · 10.1074/jbc.m412584200

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Innate immune recognition
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., & Bauer, S. (2004) · Science · doi:10.1126/science.1093620 · Cited by 3,947
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444
Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway
Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O., Sugiyama, M., Okabe, M., Takeda, K., et al. (2003) · Science · doi:10.1126/science.1087262 · Cited by 3,286
IKKε and TBK1 are essential components of the IRF3 signaling pathway
Fitzgerald, K. A., McWhirter, S. M., Faia, K. L., Rowe, D. C., Latz, E., Golenbock, D. T., Coyle, A. J., Liao, S.-M., & Maniatis, T. (2003) · Nature Immunology · doi:10.1038/ni921 · Cited by 2,680
Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway
Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., Horiuchi, T., Tomizawa, H., Takeda, K., & Akira, S. (2002) · Nature Immunology · doi:10.1038/ni758 · Cited by 2,580
The Nature of the Principal Type 1 Interferon-Producing Cells in Human Blood
Siegal, F. P., Kadowaki, N., Shodell, M., Fitzgerald-Bocarsly, P. A., Shah, K., Ho, S., Antonenko, S., & Liu, Y.-J. (1999) · Science · doi:10.1126/science.284.5421.1835 · Cited by 2,293
Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens
Kadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964
Recognition of single-stranded RNA viruses by Toll-like receptor 7
Lund, J. M., Alexopoulou, L., Sato, A., Karow, M. L., Adams, N. C., Gale, N. W., Iwasaki, A., & Flavell, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400937101 · Cited by 1,854

Show all 72 references

Research works printed but not linked: 4

Chuang, 2000, Eur. Cytokine Netw., 11, 372
Du, 2000, Eur. Cytokine Netw., 11, 362
von Krogh, 2001, Eur. J. Dermatol., 11, 598
Maniatis, 1986, Harvey Lect., 82, 71

Sorted by citations

Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
Mogensen, T. H. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00046-08 · Cited by 3,296
Toll-like Receptors and the Control of Immunity
Fitzgerald, K. A., & Kagan, J. C. (2020) · Cell · doi:10.1016/j.cell.2020.02.041 · Cited by 2,168
Innate immune recognition of viral infection
Kawai, T., & Akira, S. (2006) · Nature Immunology · doi:10.1038/ni1303 · Cited by 1,899
TLR signaling
Kawai, T., & Akira, S. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401850 · Cited by 1,894
IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors
Honda, K., & Taniguchi, T. (2006) · Nature reviews. Immunology · doi:10.1038/nri1900 · Cited by 1,716
Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures
Randall, R. E., & Goodbourn, S. (2007) · Journal of General Virology · doi:10.1099/vir.0.83391-0 · Cited by 1,609
Toll-like receptors in systemic autoimmune disease
Marshak-Rothstein, A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1957 · Cited by 1,116
Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity
Duan, T., Du, Y., Xing, C., Wang, H. Y., & Wang, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.812774 · Cited by 1,080
MicroRNA‐146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins
Tang, Y., Luo, X., Cui, H., Xu-ming, N., Yuan, M., Guo, Y., Huang, X., Zhou, H., de Vries, N., Tak, P. P., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24436 · Cited by 747
Recognition and Signaling by Toll-Like Receptors
West, A. P., Koblansky, A. A., & Ghosh, S. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.122303.115827 · Cited by 736
Sexual Dimorphism in Innate Immunity
Jaillon, S., Berthenet, K., & Garlanda, C. (2017) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-017-8648-x · Cited by 670
Pathogen recognition with Toll-like receptors
Kawai, T., & Akira, S. (2005) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.02.007 · Cited by 589
Decoding Toll-like receptors: Recent insights and perspectives in innate immunity
Kawai, T., Ikegawa, M., Ori, D., & Akira, S. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.004 · Cited by 593
Innate Immunity in the Respiratory Epithelium
Parker, D., & Prince, A. S. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0011rt · Cited by 474
TLR signalling and activation of IRFs: revisiting old friends from the NF-κB pathway
Moynagh, P. N. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.06.009 · Cited by 336
The interleukin-1 receptor-associated kinases: Critical regulators of innate immune signalling
Flannery, S. M., & Bowie, A. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.020 · Cited by 316
The impact of interferon-regulatory factors to macrophage differentiation and polarization into M1 and M2
Chistiakov, D. A., Myasoedova, V. A., Revin, V. V., Orekhov, A. N., & Bobryshev, Y. V. (2018) · Immunobiology · doi:10.1016/j.imbio.2017.10.005 · Cited by 311
IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling
Lazear, H. M., Lancaster, A., Wilkins, C., Suthar, M. S., Huang, A., Vick, S. C., Clepper, L., Thackray, L., Brassil, M. M., Virgin, H. W., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003118 · Cited by 296
Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus
Phipps, S., Lam, C. E., Mahalingam, S., Newhouse, M. J., Ramirez, R., Rosenberg, H. F., Foster, P. S., & Matthaei, K. I. (2007) · Blood · doi:10.1182/blood-2007-01-071340 · Cited by 312
Toll-like receptors (TLRs) in aquatic animals: Signaling pathways, expressions and immune responses
Rauta, P. R., Samanta, M., Dash, H. R., Nayak, B., & Das, S. (2013) · Immunology Letters · doi:10.1016/j.imlet.2013.11.013 · Cited by 306
NOD2, RIP2 and IRF5 Play a Critical Role in the Type I Interferon Response to Mycobacterium tuberculosis
Pandey, A. K., Yang, Y., Jiang, Z., Fortune, S. M., Coulombe, F., Behr, M. A., Fitzgerald, K. A., Sassetti, C. M., & Kelliher, M. A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000500 · Cited by 292
Systemic lupus erythematosus: all roads lead to type I interferons
Pascual, V., Farkas, L., & Banchereau, J. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.09.014 · Cited by 285
The IRF family, revisited
Paun, A., & Pitha, P. M. (2007) · Biochimie · doi:10.1016/j.biochi.2007.01.014 · Cited by 277
Sex Differences in Plasmacytoid Dendritic Cell Levels of IRF5 Drive Higher IFN-α Production in Women
Griesbeck, M., Ziegler, S. M., Laffont, S., Smith, N., Chauveau, L., Tomezsko, P. J., Sharei, A., Kourjian, G., Porichis, F., Hart, M. G., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501684 · Cited by 246
Toll-Like Receptor 3 Is a Potent Negative Regulator of Axonal Growth in Mammals
Cameron, J. S., Alexopoulou, L., Sloane, J. A., DiBernardo, A., Ma, Y., Kosaras, B., Flavell, R. A., Strittmatter, S. M., Volpe, J. J., Sidman, R. L., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4290-06.2007 · Cited by 236
TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7–9
Heinz, L. X., Lee, J., Kapoor, U., Kartnig, F., Sedlyarov, V., Παπακώστας, Κ., César‐Razquin, A., Essletzbichler, P., Goldmann, U., Stefanovic, A., et al. (2020) · Nature · doi:10.1038/s41586-020-2282-0 · Cited by 233
Role of type I interferons in the activation of autoreactive B cells
Kiefer, K., Oropallo, M. A., Cancro, M. P., & Marshak‐Rothstein, A. (2012) · Immunology and Cell Biology · doi:10.1038/icb.2012.10 · Cited by 229
Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression
Yanai, H., Chen, H.-M., Inuzuka, T., Kondo, S., Mak, T. W., Takaoka, A., Honda, K., & Taniguchi, T. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611559104 · Cited by 219
Antidepressant therapies inhibit inflammation and microglial M1-polarization
Kalkman, H. O., & Feuerbach, D. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.04.001 · Cited by 212
IRAK-2 Participates in Multiple Toll-like Receptor Signaling Pathways to NFκB via Activation of TRAF6 Ubiquitination
Keating, S. E., Maloney, G., Moran, E. M., & Bowie, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705266200 · Cited by 210
Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis
Sigurðsson, S., Padyukov, L., Kurreeman, F. A. S., Liljedahl, U., Wiman, A.-C., Alfredsson, L. S., Toes, R. E. M., Rönnelid, J., Klareskog, L., Huizinga, T. W. J., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22704 · Cited by 202
Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells
Schmitz, F., Heit, A., Dreher, S., Eisenächer, K., Mages, J., Haas, T., Krug, A., Janssen, K., Kirschning, C. J., & Wagner, H. (2008) · European Journal of Immunology · doi:10.1002/eji.200838761 · Cited by 212
Differential Response of Dendritic Cells to Human Metapneumovirus and Respiratory Syncytial Virus
Guerrero-Plata, A., Casola, A., Suárez, G., Yu, X., Spetch, L., Peeples, M. E., & Garofalo, R. P. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0287oc · Cited by 193
Interferon-β Production via Dectin-1-Syk-IRF5 Signaling in Dendritic Cells Is Crucial for Immunity to C. albicans
del Fresno, C., Soulat, D., Roth, S., Blazek, K. D., Udalova, I. A., Sancho, D., Ruland, J., & Ardavín, C. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.010 · Cited by 196
The IKK-related kinases: from innate immunity to oncogenesis
Clément, J.-F., Meloche, S., & Servant, M. J. (2008) · Cell Research · doi:10.1038/cr.2008.273 · Cited by 189
Murine Dendritic Cell Type I IFN Production Induced by Human IgG-RNA Immune Complexes Is IFN Regulatory Factor (IRF)5 and IRF7 Dependent and Is Required for IL-6 Production
Yasuda, K., Richez, C., Maciaszek, J. W., Agrawal, N., Akira, S., Marshak‐Rothstein, A., & Rifkin, I. R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6876 · Cited by 181
The TLR and IL-1 signalling network at a glance
Cohen, P. (2014) · Journal of Cell Science · doi:10.1242/jcs.149831 · Cited by 186
Double-Stranded RNA Induces an Antiviral Defense Status in Epidermal Keratinocytes through TLR3-, PKR-, and MDA5/RIG-I-Mediated Differential Signaling
Kalali, B. N., Köllisch, G. V., Mages, J., Müller, T. R., Bauer, S., Wagner, H., Ring, J., Lang, R., Mempel, M., & Ollert, M. W. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2694 · Cited by 186
The Toll for Trafficking: Toll-Like Receptor 7 Delivery to the Endosome
Petes, C., Odoardi, N., & Gee, K. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01075 · Cited by 177
MUC1 Mucin Is a Negative Regulator of Toll-Like Receptor Signaling
Ueno, K., Koga, T., Kato, K., Golenbock, D. T., Gendler, S. J., Kai, H., & Kim, K. C. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0336rc · Cited by 172
TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis
Kawagoe, T., Takeuchi, O., Takabatake, Y., Kato, H., Isaka, Y., Tsujimura, T., & Akira, S. (2009) · Nature Immunology · doi:10.1038/ni.1771 · Cited by 172
Immunopathogenesis of Staphylococcus aureus pulmonary infection
Parker, D., & Prince, A. S. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0291-7 · Cited by 176
Recent insights into the structure of Toll-like receptors and post-translational modifications of their associated signalling proteins
Carpenter, S. B., & O'Neill, L. A. J. (2009) · Biochemical Journal · doi:10.1042/bj20090616 · Cited by 169
Estrogen Receptor-Dependent Regulation of Dendritic Cell Development and Function
Laffont, S., Seillet, C., & Guéry, J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00108 · Cited by 170
Type I interferon signaling, regulation and gene stimulation in chronic virus infection
Lukhele, S., Boukhaled, G. M., & Brooks, D. G. (2019) · Seminars in Immunology · doi:10.1016/j.smim.2019.05.001 · Cited by 173
TLR7 Is Involved in Sequence-Specific Sensing of Single-Stranded RNAs in Human Macrophages
Gantier, M. P., Tong, S., Behlke, M. A., Xu, D., Phipps, S., Foster, P. S., & Williams, B. R. G. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2117 · Cited by 163
Two Discrete Promoters Regulate the Alternatively Spliced Human Interferon Regulatory Factor-5 Isoforms
Mancl, M. E., Hu, G., Sangster‐Guity, N., Olshalsky, S. L., Hoops, K. E. M., Fitzgerald-Bocarsly, P. A., Pitha, P. M., Pinder, K. E., & Barnes, B. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500543200 · Cited by 160
Adaptor usage and Toll‐like receptor signaling specificity
Dunne, A., & O'Neill, L. A. J. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.04.024 · Cited by 155
TIR, CARD and PYRIN: three domains for an antimicrobial triad
Werts, C., Girardin, S. E., & Philpott, D. J. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401890 · Cited by 156
Lung epithelium as a sentinel and effector system in pneumonia – molecular mechanisms of pathogen recognition and signal transduction
Hippenstiel, S., Opitz, B., Schmeck, B., & Suttorp, N. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-97 · Cited by 158
Direct Inhibition of IRF-Dependent Transcriptional Regulatory Mechanisms Associated With Disease
Antonczyk, A., Krist, B., Sajek, M., Sekrecka, A., Piaszyk-Borychowska, A., Plens-Gałąska, M., Wesoły, J., & Bluyssen, H. A. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01176 · Cited by 162
Phagosomal signaling by Borrelia burgdorferi in human monocytes involves Toll-like receptor (TLR) 2 and TLR8 cooperativity and TLR8-mediated induction of IFN-β
Cervantes, J., Dunham-Ems, S. M., Vake, C. J. L., Petzke, M. M., Sahay, B., Sellati, T. J., Radolf, J. D., & Salazar, J. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013776108 · Cited by 145
The role of type I interferons in TLR responses
Noppert, S. J., Fitzgerald, K. A., & Hertzog, P. J. (2007) · Immunology & Cell Biology · doi:10.1038/sj.icb.7100099 · Cited by 135
Self-citation
Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers
López‐Mejías, R., Castañeda, S., González‐Juanatey, C., Corrales, A., Ferraz‐Amaro, I., Genre, F., Remuzgo‐Martínez, S., Rodríguez‐Rodríguez, L., Blanco, R., Llorca, J., et al. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.07.026 · Cited by 138
Th1, Th2, and Th17 cytokines in systemic lupus erythematosus
Yusoff, F. M., Wong, K. K., & Redzwan, N. M. (2019) · Autoimmunity · doi:10.1080/08916934.2019.1693545 · Cited by 138
Viral recognition and the antiviral interferon response
Dalskov, L., Gad, H. H., & Hartmann, R. (2023) · The EMBO Journal · doi:10.15252/embj.2022112907 · Cited by 139
Induction of IFN-β and the Innate Antiviral Response in Myeloid Cells Occurs through an IPS-1-Dependent Signal That Does Not Require IRF-3 and IRF-7
Daffis, S., Suthar, M. S., Szretter, K. J., Gale, M., & Diamond, M. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000607 · Cited by 133
Human Blood CD1c+ Dendritic Cells Encompass CD5high and CD5low Subsets That Differ Significantly in Phenotype, Gene Expression, and Functions
Yin, X., Yu, H., Jin, X., Li, J., Guo, H., Shi, Q., Yin, Z., Xu, Y., Wang, X., Liu, R., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1600193 · Cited by 132
Regulation of innate immune signaling by IRAK proteins
Pereira, M. C. A., & Gazzinelli, R. T. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1133354 · Cited by 134
Functional Characterization of Murine Interferon Regulatory Factor 5 (IRF-5) and Its Role in the Innate Antiviral Response
Paun, A., Reinert, J. T., Jiang, Z., Medin, C. L., Balkhi, M. Y., Fitzgerald, K. A., & Pitha, P. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800501200 · Cited by 132
Glucocorticoids and the innate immune system: crosstalk with the toll-like receptor signaling network
Chinenov, Y., & Rogatsky, I. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.04.014 · Cited by 133
Manipulation of the Toll-Like Receptor 7 Signaling Pathway by Epstein-Barr Virus
Martin, H. J., Lee, J. M., Walls, D., & Hayward, S. D. (2007) · Journal of Virology · doi:10.1128/jvi.01122-07 · Cited by 130
Recognition of viral single-stranded RNA by Toll-like receptors☆
Diebold, S. S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.004 · Cited by 131
Functional Regulation of MyD88-Activated Interferon Regulatory Factor 5 by K63-Linked Polyubiquitination
Balkhi, M. Y., Fitzgerald, K. A., & Pitha, P. M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00662-08 · Cited by 128
TLR8 Senses Staphylococcus aureus RNA in Human Primary Monocytes and Macrophages and Induces IFN-β Production via a TAK1–IKKβ–IRF5 Signaling Pathway
Bergstrøm, B., Aune, M. H., Awuh, J. A., Kojen, J. F., Blix, K. J., Ryan, L., Flo, T. H., Mollnes, T. E., Espevik, T., & Stenvik, J. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403176 · Cited by 123
YopJ targets TRAF proteins to inhibit TLR-mediated NF-?B, MAPK and IRF3 signal transduction
Sweet, C. R., Conlon, J. E., Golenbock, D. T., Goguen, J. D., & Silverman, N. S. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00990.x · Cited by 126
Activity and Regulation of Alpha Interferon in Respiratory Syncytial Virus and Human Metapneumovirus Experimental Infections
Guerrero-Plata, A., Baron, S., Poast, J. S., Adegboyega, P. A., Casola, A., & Garofalo, R. P. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10190-10199.2005 · Cited by 124
Insights into interferon regulatory factor activation from the crystal structure of dimeric IRF5
Chen, W., Lam, S. S., Srinath, H., Jiang, Z., Correia, J. J., Schiffer, C. A., Fitzgerald, K. A., Lin, K. F., & Royer, W. E. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1496 · Cited by 123
Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes
Patinote, C., Karroum, N. B., Moarbess, G., Cirnat, N., Kassab, I., Bonnet, P., & Deleuze‐Masquéfa, C. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112238 · Cited by 127
Genetic variants and disease‐associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus
Feng, D., Stone, R. C., Eloranta, M., Sangster‐Guity, N., Nordmark, G., Sigurðsson, S., Wang, C., Alm, G. V., Syvänen, A., Rönnblom, L., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27223 · Cited by 123
Interferon Alpha in Systemic Lupus Erythematosus
Niewold, T. B., Clark, D. N., Salloum, R., & Poole, B. D. (2010) · BioMed Research International · doi:10.1155/2010/948364 · Cited by 122
Toll‐like receptor interactions: tolerance of MyD88‐dependent cytokines but enhancement of MyD88‐independent interferon‐β production
Broad, A., Kirby, J. A., & Jones, D. E. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02485.x · Cited by 122
Signaling through IFN Regulatory Factor-5 Sensitizes p53-Deficient Tumors to DNA Damage–Induced Apoptosis and Cell Death
Hu, G., Mancl, M. E., & Barnes, B. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0583 · Cited by 121
Negative regulation of type I IFN signaling
Arimoto, K.-I., Miyauchi, S., Stoner, S. A., Fan, J.-B., & Zhang, D.-E. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.2mir0817-342r · Cited by 117
Advances and challenges in targeting IRF5, a key regulator of inflammation
Almuttaqi, H., & Udalova, I. A. (2018) · FEBS Journal · doi:10.1111/febs.14654 · Cited by 116
Study of pathway cross-talk interactions with NF-κB leading to its activation via ubiquitination or phosphorylation: A brief review
Ghosh, S., & Dass, J. F. P. (2016) · Gene · doi:10.1016/j.gene.2016.03.008 · Cited by 120
Type I Interferon in Systemic Lupus Erythematosus
Crow, M. K. (2007) · Springer eBooks · doi:10.1007/978-3-540-71329-6_17 · Cited by 113
SARS-CoV Regulates Immune Function-Related Gene Expression in Human Monocytic CellsPreprint
Hu, W., Yen, Y.-T., Singh, S., Kao, C., & Wu‐Hsieh, B. A. (2011) · Nature Precedings · doi:10.1089/vim.2011.0099 · Cited by 113
Lyn Kinase Suppresses the Transcriptional Activity of IRF5 in the TLR-MyD88 Pathway to Restrain the Development of Autoimmunity
Ban, T., Sato, G. R., Nishiyama, A., Akiyama, A., Takasuna, M., Umehara, M., Suzuki, S., Ichino, M., Matsunaga, S., Kimura, A., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.07.015 · Cited by 106
Characterization of the Interferon-Producing Cell in Mice Infected with Listeria monocytogenes
Stockinger, S., Kastner, R., Kernbauer, E., Pilz, A., Westermayer, S., Reutterer, B., Soulat, D., Stengl, G., Vogl, C., Frenz, T., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000355 · Cited by 108
Epstein–Barr Virus Infection Induces Aberrant TLR Activation Pathway and Fibroblast–Myofibroblast Conversion in Scleroderma
Farina, A., Cirone, M., York, M. R., Lenna, S., Padilla, C. M., McLaughlin, S. R., Faggioni, A., Lafyatis, R., Trojanowska, M. E., & Farina, G. A. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.423 · Cited by 105
The role of differential expression of human interferon-A genes in antiviral immunity
Génin, P., Vaccaro, A., & Civas, A. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.07.005 · Cited by 105
Chronic TLR7 and TLR9 signaling drives anemia via differentiation of specialized hemophagocytes
Akilesh, H. M., Buechler, M. B., Duggan, J. M., Hahn, W. O., Matta, B., Sun, X., Gessay, G. M., Whalen, E., Mason, M. J., Presnell, S., et al. (2019) · Science · doi:10.1126/science.aao5213 · Cited by 103
IKKβ is an IRF5 kinase that instigates inflammation
Ren, J., Chen, X., & Chen, Z. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1418516111 · Cited by 104
Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: Support for a crucial role of intron 1 polymorphisms
Kawasaki, A., Kyogoku, C., Ohashi, J., Miyashita, R., Hikami, K., Kusaoi, M., Tokunaga, K., Takasaki, Y., Hashimoto, H., Behrens, T. W., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23216 · Cited by 102
Innate Immune Signaling and Its Role in Metabolic and Cardiovascular Diseases
Xu, M. M., Liu, P. P., & Li, H. (2018) · Physiological Reviews · doi:10.1152/physrev.00065.2017 · Cited by 100
Protein kinase IKKβ-catalyzed phosphorylation of IRF5 at Ser462 induces its dimerization and nuclear translocation in myeloid cells
López‐Peláez, M., Lamont, D. J., Peggie, M. W., Shpiro, N., Gray, N. S., & Cohen, P. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1418399111 · Cited by 100
Structural insights into interferon regulatory factor activation
Chen, W., & Royer, W. E. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.12.005 · Cited by 100
HIV–Host Cell Interactions
Masenga, S. K., Mweene, B. C., Luwaya, E. L., Muchaili, L., Chona, M., & Kirabo, A. (2023) · Cells · doi:10.3390/cells12101351 · Cited by 114
The crucial regulatory role of type I interferon in inflammatory diseases
Ji, L., Li, T., Chen, H., Yang, Y., Liu, J., Liu, J., Qiao, W., & Chen, H. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01188-z · Cited by 107
Toll-like receptor agonists in the treatment of chronic lymphocytic leukemia
Spaner, D., & Masellis-Smith, A. (2006) · Leukemia · doi:10.1038/sj.leu.2404456 · Cited by 102
IFN Regulatory Factor 5 Is Required for Disease Development in the FcγRIIB−/−Yaa and FcγRIIB−/− Mouse Models of Systemic Lupus Erythematosus
Richez, C., Yasuda, K., Bonegio, R. G. B., Watkins, A. A., Aprahamian, T. R., Busto, P., Richards, R. J., Liu, C. L., Cheung, R. K., Utz, P. J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901748 · Cited by 98
Interferon regulatory factor 7‐mediated responses are defective in cord blood plasmacytoid dendritic cells
Danis, B., George, T. C., Goriely, S., Dutta, B., Renneson, J., Gatto, L., Fitzgerald-Bocarsly, P. A., Marchant, A., Goldman, M., Willems, F., et al. (2008) · European Journal of Immunology · doi:10.1002/eji.200737760 · Cited by 97
IRF5 is required for late-phase TNF secretion by human dendritic cells
Krausgruber, T., Saliba, D. G., Ryzhakov, G., Lanfrancotti, A., Blazek, K. D., & Udalova, I. A. (2010) · Blood · doi:10.1182/blood-2010-01-263020 · Cited by 97
Inhibition of IRF5 hyperactivation protects from lupus onset and severity
Song, S., De, S., Nelson, V. L., Chopra, S., LaPan, M., Kampta, K., Sun, S., He, M., Thompson, C. D., Li, D., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci120288 · Cited by 95
Innate recognition of intracellular pathogens: detection and activation of the first line of defense
RASMUSSEN, S. B., Reinert, L. S., & Paludan, S. R. (2009) · Apmis · doi:10.1111/j.1600-0463.2009.02456.x · Cited by 101
Increased expression of Toll-like receptors (TLRs) 7 and 9 and other cytokines in systemic lupus erythematosus (SLE) patients: Ethnic differences and potential new targets for therapeutic drugs
Lyn‐Cook, B. D., Xie, C., Oates, J. R., Treadwell, E. L., Word, B. R., Hammons, G., & Wiley, K. L. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.05.001 · Cited by 93
A compass that points to lupus: genetic studies on type I interferon pathway
Kyogoku, C., & Tsuchiya, N. (2007) · Genes and Immunity · doi:10.1038/sj.gene.6364409 · Cited by 91
Resiquimod and other immune response modifiers as vaccine adjuvants
Tomai, M. A., Miller, R. L., Lipson, K. E., Kieper, W. C., Zarraga, I. E., & Vasilakos, J. P. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.5.835 · Cited by 88
IRF ‐5 and NF ‐κ B p50 co‐regulate IFN ‐β and IL ‐6 expression in TLR 9‐stimulated human plasmacytoid dendritic cells
Steinhagen, F., McFarland, A. P., Rodríguez, L. G., Tewary, P., Jarret, A. P., Savan, R., & Klinman, D. M. (2013) · European Journal of Immunology · doi:10.1002/eji.201242792 · Cited by 86

Authors: Schoenemeyer, A., Barnes, B. J., Mancl, M. E., Latz, E., Goutagny, N., Pitha, P. M., Fitzgerald, K. A., & Golenbock, D. T.
Affiliations: University of Massachusetts Chan Medical School (US)
Johns Hopkins University (US)
Corresponding author: Fitzgerald, Katherine A.
Golenbock, Douglas T.
ORCID: Barnes, Betsy J.
Latz, Eicke
Fitzgerald, Katherine A.
Golenbock, Douglas T.
Venue: Journal of Biological Chemistry
Publisher: Elsevier BV
Published: 2005-04
Volume: 280
Issue: 17
Pages: 17005-17012
ISSN: 0021-9258 (ISSN-L)
DOI: 10.1074/jbc.m412584200
OpenAlex: W2040706148
Cited by: 411
References: 72
Citations by year: 2026: 7 · 2025: 8 · 2024: 16 · 2023: 16 · 2022: 11 · 2021: 13 · 2020: 16 · 2019: 21 · 2018: 23 · 2017: 25 · 2016: 11 · 2015: 14 · 2014: 25 · 2013: 17 · 2012: 20
FWCI: 11.11
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 5677 d)
Locations: Journal of Biological Chemistry (publishedVersion, cc-by)
PubMed (publishedVersion)
eScholarship@UMassChan (submittedVersion)
Funders: National Cancer Institute (R01A1/CA19737-19A1)
National Institute of General Medical Sciences (GM 54060)
National Institute of Allergy and Infectious Diseases (AI-52455, AI 49309, R01AI049309)
Topics: Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords: IRF5, IRF7, TLR7, TLR8, TLR7 signaling, type I interferon, MyD88, TRAF6, IRAK1, IRF3, interferon regulatory factors, R848, innate immunity
MeSH terms: Antigens, Differentiation, Biological Assay, Cell Line, DNA-Binding Proteins, Dose-Response Relationship, Drug, Glutathione Transferase, Humans, Interferon Type I, Ligands, Lipopolysaccharides, Membrane Glycoproteins, Models, Biological, Phosphorylation, Receptors, Cell Surface, Receptors, Immunologic, Recombinant Fusion Proteins, RNA, Double-Stranded, Time Factors, Transcription Factors, Transfection, Signal Transduction, Genes, Reporter, Electroporation, Microscopy, Confocal, Reverse Transcriptase Polymerase Chain Reaction, RNA Interference, RNA, Small Interfering, Adaptor Proteins, Signal Transducing, Interferon Regulatory Factors, Interferon Regulatory Factor-3, Interferon Regulatory Factor-7, Toll-Like Receptors, Toll-Like Receptor 3, Toll-Like Receptor 4, Toll-Like Receptor 7, Toll-Like Receptor 8, Myeloid Differentiation Factor 88

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Interferon Regulatory Factor, IRF5, Is a Central Mediator of Toll-like Receptor 7 Signaling

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks